In recent years, decreased expression of PTPN12 has been found in several human cancers and correlated with the aggressiveness and/or poor prognosis of breast cancer and esophageal cancer [9], [10], [13], [14]. This evidence concerns the gene PTPN12 and esophageal cancer.